SYNLOGIC, INC.

Profile

Company Names

SYNLOGIC, INC.
MIRNA THERAPEUTICS, INC.

Addresses

301 BINNEY STREET, SUITE 402, CAMBRIDGE, MA 02142

2150 WOODWARD ST., SUITE 100, AUSTIN, TX 78744

Phone Numbers

617-401-9975
512-681-5200

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$140,539,514.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2019-06-11 
$79,999,992.00 
$79,999,992.00 
$0.00 
Equity 
3
2015-03-31 
$41,789,527.00 
$45,000,000.00 
$3,210,473.00 
Equity 
2
2012-10-22 
$17,249,995.00 
$34,499,990.00 
$17,249,995.00 
Equity 
1
2011-08-10 
$1,500,000.00 
$1,500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LARRY 
 
ALLEVA 
DIRECTOR
AOIFE 
 
BRENNAN 
EXECUTIVE OFFICER, DIRECTOR
CASI 
 
DEYOUNG 
EXECUTIVE OFFICER
CHRISTOPHER 
EARL 
DIRECTOR
COREY 
GOODMAN 
DIRECTOR
LYNNE 
 
HOHLFELD 
EXECUTIVE OFFICER
PATRICIA 
 
HURTER 
DIRECTOR
JON 
 
IRVIN 
EXECUTIVE OFFICER
ELAINE 
JONES 
DIRECTOR
SINIL 
 
KIM 
EXECUTIVE OFFICER
PAUL 
 
LAMMERS 
EXECUTIVE OFFICER, DIRECTOR
EVAN 
MELROSE 
DIRECTOR
RICHARD 
P. 
SHEA 
DIRECTOR
TODD 
 
SHEGOG 
EXECUTIVE OFFICER
CLAY 
 
SIEGALL 
DIRECTOR
ANA 
 
WARD 
EXECUTIVE OFFICER
ANA 
WARD 
EXECUTIVE OFFICER
MATTHEW 
 
WINKLER 
DIRECTOR
MATTHEW 
WINKLER 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-06-11 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-03-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
FERGHANA SECURITIES, INC.